Isolation of SARS-CoV-2 strains carrying a nucleotide mutation, leading to a stop codon in the ORF 6 protein.


Journal

Emerging microbes & infections
ISSN: 2222-1751
Titre abrégé: Emerg Microbes Infect
Pays: United States
ID NLM: 101594885

Informations de publication

Date de publication:
Dec 2021
Historique:
pubmed: 3 2 2021
medline: 26 2 2021
entrez: 2 2 2021
Statut: ppublish

Résumé

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was isolated from the oro/pharyngeal swabs of two Italian COVID-19 patients, physicians in a COVID-19 division hospital, with different courses of the disease. The complete genome sequences show that the two isolates belong to the B1.1 lineage, but contain a nucleotide mutation in the ORF6, leading to a stop codon and to the deletion of 6 amino acids in the C terminus. This deletion was unique, compared to the currently available sequences deposited in the GISAID and GenBank database. It did not affect the in vitro viral replication, neither the neutralizing activities of the patients' antibodies. Based on homology analysis with other Coronaviruses, the two isolated lacked the ORF6 aminoacidic portion responsible for the inhibition of the antiviral Interferon (IFN)-based host response. IFN seems to have a dual role of in SARS-CoV-2 infected patients: not only antiviral activity, but also a detrimental role in case of excessive production. A deletion in the SARS-CoV-2 ORF6 protein might have a specific, still unknown role in the viral pathogenesis.

Identifiants

pubmed: 33525998
doi: 10.1080/22221751.2021.1884003
pmc: PMC7894437
doi:

Substances chimiques

Codon, Terminator 0
ORF6 protein, SARS-CoV-2 0
Viral Proteins 0

Types de publication

Case Reports Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

252-255

Références

Cytokine. 2018 Apr;104:8-13
pubmed: 29414327
Science. 2020 Aug 7;369(6504):712-717
pubmed: 32527928
J Virol. 2007 Jan;81(2):548-57
pubmed: 17108024
Cell Mol Immunol. 2020 May;17(5):533-535
pubmed: 32203188
J Clin Virol. 2020 Oct;131:104585
pubmed: 32818852
Nat Commun. 2021 Jan 4;12(1):63
pubmed: 33397909
Virus Res. 2020 Sep;286:198074
pubmed: 32589897
Clin Exp Immunol. 2004 Apr;136(1):95-103
pubmed: 15030519
Emerg Microbes Infect. 2020 Dec;9(1):1418-1428
pubmed: 32529952
Nature. 2006 Jan 19;439(7074):344-8
pubmed: 16327776
J Med Virol. 2005 Aug;76(4):435-40
pubmed: 15977248
J Virol. 2007 Sep;81(18):9812-24
pubmed: 17596301

Auteurs

Serena Delbue (S)

Laboratory of Molecular Virology, Department of Biomedical, Surgical and Dental Sciences, University of Milano, Milano, Italy.

Sarah D'Alessandro (S)

Laboratory of Molecular Virology, Department of Biomedical, Surgical and Dental Sciences, University of Milano, Milano, Italy.

Lucia Signorini (L)

Laboratory of Molecular Virology, Department of Biomedical, Surgical and Dental Sciences, University of Milano, Milano, Italy.

Maria Dolci (M)

Laboratory of Molecular Virology, Department of Biomedical, Surgical and Dental Sciences, University of Milano, Milano, Italy.

Elena Pariani (E)

Department of Biomedical Science for Health, University of Milano, Milano, Italy.

Michele Bianchi (M)

Department of Cardiology, Istituto Clinico Città Studi, Milano, Italy.

Stefania Fattori (S)

Interdepartmental Center of Diabetic Foot, Istituto Clinico Città Studi, Milano, Italy.

Annalisa Modenese (A)

Laboratory of clinical analysis, Istituto Clinico Città Studi, Milano, Italy.

Cristina Galli (C)

Department of Biomedical Science for Health, University of Milano, Milano, Italy.

Ivano Eberini (I)

Department of Pharmacological and Biomolecular Sciences & DSRC, University of Milano, Milano, Italy.

Pasquale Ferrante (P)

Laboratory of Molecular Virology, Department of Biomedical, Surgical and Dental Sciences, University of Milano, Milano, Italy.
Health Direction, Istituto Clinico Città Studi, Milano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH